FINWIRES · TerminalLIVE
FINWIRES

China's NMPA Approves Eisai's Early Alzheimer's, Dementia Drug

By

China's National Medical Products Administration (NMPA) approved Eisai's (TYO:4523) anti-amyloid beta protofibril antibody Leqembi, or lecanemab, as an initiation treatment for mild cognitive impairment due to Alzheimer's disease or mild AD dementia.

Leqembi SC-AI is a self-administered autoinjector given once weekly at 500 mg through two 250 mg injections, according to a Thursday filing with the Japan bourse.

The approval adds at-home subcutaneous treatment to the existing every-two-week intravenous regimen, with patients able to switch between the two administration methods during treatment, the release said.

Leqembi was launched in China in June 2024, it said.

Shares of Eisai rose nearly 2% at market close.

What else is happening in Asia?

Asia

Market Chatter: Komatsu to Raise Construction Equipment Supply to North America on Greater Demand for Data Centers

Komatsu (TYO:6301) looks to increase product supply to North America to meet demand for data center construction amid the AI boon, Nikkei Asia reported Wednesday, citing CFO Hiroshi Hosotani.The company's sales of construction equipment in the region grew 29% year over year, Hosotani said in an interview with the news outlet.The data center market could further grow for another five years, given that building data centers can continue for a long time, the executive said in the interview.The company will also focus on improving inventory levels through optimal production planning to anchor free cash flow, the report cited Hosotani as saying.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

TYO:6301
Asia

Xingye Silver & Tin Mining's Unit Resumes Operations After Accident; Shares Up 4%

Inner Mongolia Xingye Silver & Tin Mining's (SHE:000426) unit, Xiwuzhumuqin Banner Yinman Mining, resumed operations after being shut down due to an accident that brought one casualty, according to a Shenzhen bourse filing on Thursday.Yinman Mining's production at its mining area and its mineral processing tailings system were temporarily suspended following a work accident during production at the mine's underground Third Mining Area on July 26.The metals miner's shares jumped 4% during the morning trade.

SHE:000426
Asia

Kafelaku Coffee Upsizes Private Placement to HK$11.6 Million

Kafelaku Coffee Holding (HKG:1869) has revised the terms for its private placement offering to raise HK$11.6 million, up from HK$11 million, according to a Wednesday bourse filing.The specialty coffee chain said it will now offer 282.1 million shares at HK$0.041 apiece, up from HK$0.039. The new offer price represents an 18% discount to the stock's last closing price.Kafelaku also extended the offering closing date to Sept. 23 from Sept. 2.Shares of the company are down 4% in open market trading on the HKEX.

HKG:1869